• CONCLUSION: Specific HMGB1 siRNA can inhibit the expression of HMGB1. The effect may be attributed to inhibit the proliferation and promote cell apoptosis.
Effect on proliferation and apoptosis of retinoblastoma cell by RNA inhibiting high mobility group protein box-1 expression INTRODUCTION R etinoblastoma (Rb) is a most common intraocular malignant tumor of infant and young children [1] . It ranks first in the incidence of malignant tumors of the eye, and there is a gradual upward trend in recent years in China [2] . The existing treatments for Rb include chemotherapy, laser photocoagulation, frozen, radiotherapy and eyeball enucleation etc. The preferred treatment option is chemotherapy combined with local consolidation therapy, such as photocoagulation and frozen. However, this scheme has poor efficacy for patients with advanced Rb, while chemotherapy accompanied by severe side effects, and faced with the problem of resistance to chemotherapy [3] . In recent years, the development of tumor molecular biology and genetic engineering techniques makes gene therapy become a research hotspot of cancer therapy [4] . High mobility group protein box-1 (HMGB1) is a kind of nonhistone chromatin proteins abundant in eucaryotic cell nucleus, which play an important role in the process of inflammation regulation, migration, survival and other life activities [5] [6] [7] [8] .
The high expression of HMGB1 in tumor tissue suggests that HMGB1 plays an important role in the regulation of tumor cells occurrence and development. This study investigated the expression of HMGB1 in human Rb cell lines, and observed the inhibiting effect of HMGB1 siRNA and its effect on cell proliferation and apoptosis by use of RNA interference technique to inhibit the gene expression of HMGB1 in human Rb cell lines. expression of HMGB1 Y79, the expression levels of HMGB1 mRNA were detected by RT-PCR, compared siRNA transfected group with control group showed: siRNA had inhibitory effect on the expression of HMGB1, and the inhibitory effect of siRNA1 was better (P<0.01; Figure 3 ).
MATERIALS AND METHODS

siRNA Inhibit High Mobility Group Protein Box-1 Protein Expression in Y79 Cell Detected by Western Blot
After transfected by siRNA, the HMGB1 protein level of Y79 cells significantly reduced, and siRNA1 could obviously inhibit the expression of HMGB1 protein, and there was statistically significance between the two groups on HMGB1 protein expressions (P<0.01; Figure 4 ).
Effection of High Mobility Group Protein Box-1 siRNA in Y79 Cell Proliferation Detected by MTT Assay
After being transfected by the most efficient suppression siRNA1 for 48h, Y79 cells growth was inhibited, compared to the negative control group, the difference was statistically significant (P<0.01; Figure 5 ).
Silence High Mobility Group Protein Box-1 to Induce Caspase-3 Activation in Y79 Cells
The results showed that siRNA silencing HMGB1 had significantly enhanced role on Caspase-3 activation in Y79 cells, compared with the control group, the difference was statistically significant (P<0.01; Figure 6 ). Effect of High Mobility Group Protein Box-1 siRNA on Y79 Cell Cycle After siRNA1 in vitro transfection Y79, the ratio of cells in G0-G1 cell cycle phase increased to 66.73%, higher than the negative control group (55.40%), while in interference group the ratio of cells in G2-M phase fell to 4.42%, lower than the negative control group (13.14%). After siRNA interference HMGB1, the proportion of proliferating cells reduced, and the proportion of quiescent cells increased (P<0.05; Figure 7 ). Effect of High Mobility Group Protein Box-1 siRNA on Apoptosis in Y79 Flow cytometry analysis found, after interfering with HMGB1 siRNA1, apoptosis rate of Y79 cells increased from 2.03% to 9.10%, cell apoptosis rate was significantly increased after RNA interference (P<0.05; Figure 8 ).
DISCUSSION
Because of low early attendance rate, the treatment for children with Rb was much more beyond the scope of local adaptation, so oculists often used the traditional model of enucleation, external radiation therapy which have mass greater impact on the psychology and life quality of Rb patients. With the development of molecular biology and genetic engineering, molecular targeted therapy for the treatment of Rb provide a new treatment ideas. But the mechanism of Rb is not very clear. Excessive proliferation and apoptosis inhibition of tumor tissue was considered to be one of mechanisms of Rb occurence [9] [10] . Therefore, study of the pathogenesis of Rb may discover new diagnostic markers and find a potential new target for Rb therapy. As widely present in the nucleus of eukaryotic chromatin non-histone nuclear protein, HMGB1 was named because of fast migration rate in the polyacrylamide gel electrophoresis. HMGB1, an important inflammatory mediator and proinflammatory cytokines, were researched in inflammatory and autoimmune diseases initially [11] . In recent years, because of its regulating transcription activity, people found HMGB1 with high expression levels in a variety of tumors, such as breast cancer, colon cancer, stomach cancer, liver cancer [6, [12] [13] [14] [15] , promoting T98G glioma cell proliferation by RAGE/MEK/ ERK signaling pathway, suggested that HMGB1 involving in the regulation of tumor cells occurrence and development [16] . HMGB1 is closely related to several clinicopathological parameters such as clinical staging, recurrence, metastasis and prognosis of tumors. HMGB1 also possibly accelerate tumor metastasis by a number of angiogenic factors such as VEGF, tumor necrosis factor, or secreted interferon itself as an angiogenic factor promotes angiogenesis. HMGB1 can also induce vascular endothelial cell apoptosis. Due to vascular endothelial cells are not belong to quickly update cell population, vascular endothelial cell apoptosis can reduce endothelial cells reserves and then lead to vascular endothelial fissure permeability increased, so that accelerate tumor metastasis and invasion [17] . However, the relationship between HMGB1 and human Rb is still worthy of further study. Compared with human Rb cell line and normal human retinal vascular endothelial cells lines, we found that HMGB1 expression was significantly increased in the Rb tumor cell lines in our study. It illustrated that the abnormally high expression of HMGB1 was closely related to Rb occurrence and development. In our experiment, highly efficient and specific siRNA were used to transfect human Rb Y79 cells with high expression level of HMGB1 and then made HMGB1 expression blocked. We found that cell proliferation was inhibited after 48h. We also examined the Caspase-3 activity which is closely related to cell apoptosis. Caspase-3 is part of a variety of common downstream effect or apoptosis pathway. It occupies a central position in the process of apoptosis and was called "death execution protease" [18] . Our study found that silencing activity of HMGB1 can obviously promote Caspase-3 activation and inhibit the cell cycle, and induce apoptosis of tumor cells. In our experiment, the silence of HMGB1 gene could increase apoptosis and inhibit cell proliferation in Rb tumor cells, which further proved the important role of HMGB1 in Rb occurrence and development. Some questions should still be further studied including nature of the tumor, its biological characteristics, as well as the role of multiple genes involved in different stages of tumor and other issues. This study suggests that HMGB1 plays an important role in Rb tumor cells occurrence and development, and provides a new idea for Rb treatment and research. However, there are still some deficiencies in this study. Although the reduced expression of HMGB1 by siRNA interference can inhibit proliferation and induce apoptosis, whether downregulation of HMGB1 can affect invasion and metastasis of Rb, or the specific molecular mechanisms of HMGB1 acts in occurrence and development of Rb, deserve further study.
